Shorter sampling interval in pilot - Good idea? [Design Issues]

posted by nobody – 2018-02-27 20:02 (2687 d 16:41 ago) – Posting: # 18472
Views: 4,687

Hy!

Have a drug with "normal" half-life of some hours in the mean, but considerable variability (BOTH target params). So pilot will be huuuugh and fully replicate (planned: EU submission).

Sponsor wants to make a little cheaper by having only 24 h sampling in the pilot, but considerably longer in the pivotal trial.

Good idea? Regarding sample size estimation for the pivotal (including adjusted acceptance range for Cmax, but standard acceptance range for AUC...).

Any thoughts or numbers? :-)

Οὐδείς

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,697 registered users;
92 visitors (0 registered, 92 guests [including 25 identified bots]).
Forum time: 13:44 CEST (Europe/Vienna)

Anyone who conducts an argument by appealing to authority
is not using his intelligence;
he is just using his memory.    Leonardo da Vinci

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5